کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3209388 | 1587616 | 2008 | 9 صفحه PDF | دانلود رایگان |

BackgroundDrugs have occasionally been implicated in dermatomyositis (DM) onset.ObjectiveWe sought to review case reports of drug-induced DM.MethodsArticles were gathered from MEDLINE and bibliographies of acquired reports. Causality was assessed using World Health Organization criteria. Clinical characteristics, management, and resolution were examined.ResultsIn 70 reported cases, 50% of patients were female and the median age was 57 years. Hydroxyurea was implicated in 51% of cases. All cases had pathognomonic (76%) or compatible (24%) cutaneous findings. Hydroxyurea cases lacked myositis, but myositis was described in 79.4% of nonhydroxyurea cases. Drug causality was probable (25.7%) or possible (74.3%), but not certain in any case. Most patients had underlying pathology associated with DM (44% had malignancy; 16% had rheumatoid arthritis). Of the sample, 84.3% had improvement of DM after discontinuation of the drug.LimitationsCase reports may emphasize unusual findings.ConclusionsFurther work is needed to differentiate drug effects from underlying, predisposing factors.
Journal: Journal of the American Academy of Dermatology - Volume 59, Issue 5, November 2008, Pages 872–880